Business
SANUWAVE Health Appoints Industry Veteran Andrew Walko as President
Walko brings 17 years of Manufacturing, Production, Operations, and Logistics Experience, most recently as President of Biomerics, where he led a 170-person
About this update from Sanuwave Health, Inc.
[{"type":"text","content":"Walko brings 17 years of Manufacturing, Production, Operations, and Logistics Experience, most recently as President of Biomerics, where he led a 170-person contract manufacturing organization EDEN PRAIRIE, MN, July 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (the \"Company\" or \"SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the hiring of Andrew Walko as its new President. Walko brings deep experience in contract manufacturing, supply chain management, medical device production, and logistics from his previous roles at Biomerics, Minnetronix Medical, and Integer Holdings. Prior to this, he served as operations and logistics manager for U.S. Army operations/special ops both at home and overseas. He earned his MBA from the University of Minnesota. “We are pleased to welcome Andrew to SANUWAVE at this pivotal time in our growth plans,” said CEO Morgan Frank. “His experience, energy, and attitude are going to be a strong addition to our team and provide us with the skills and talent we need to take the next steps forward in expanding our manufacturing capabilities and becoming a leader in the wound care space.” “I can’t be more thrilled to join SANUWAVE at this exciting time in its journey. We have a great opportunity in front of us to deliver critical therapy to patients and provide them with the best products and care available,” said Walko. “I look forward to contributing to the future growth of this important technology.” Andrew begins work at SANUWAVE on July 31, 2023. About SANUWAVE SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. SANUWAVE’s end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions. Forward-Looking Statements This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating...